Replimune

October 15, 2020

SITC 2020 – embargo snafu triggers the first movers

The SITC breaks its own embargo, and the ensuing chaos sees Replimune, Iovance and Incyte move.

September 30, 2020

Clinical data focus for the smallest players

Our final look at upcoming catalysts sees data expected from Replimune, TCR2 Therapeutics, Anavex and more.

October 09, 2019

SITC 2019 preview – Nextcure’s time to shine

The biotech calendar’s next key conference gets under way in a month, and a presentation by Nextcure will be a focus for some investors.